Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NextCure, Inc.NXTC · Entity 7461 | Director | June 18, 2026 | June 22, 2026 |
| Xencor IncXNCR · Entity 4487 | Director | June 16, 2026 | July 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NextCure, Inc.
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.02 · Expires 2036-06-17 | Direct | 2,340 |
Reported balance
After 2026-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 2,340 · Balance 2,340 F1: The option vests in full on the earlier of June 18, 2027 and the date of the 2027 Annual Meeting of Stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in full on the earlier of June 18, 2027 and the date of the 2027 Annual Meeting of Stockholders.
Xencor Inc
Report date June 16, 2026 · Filed July 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,642 |
Reported balance
After 2026-06-16 transaction · row 1
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 10,302 · Balance 22,642 F1: Represents restricted stock units that shall fully vest on the first anniversary of the date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.20 · Expires 2036-06-15 | Direct | 20,604 |
Reported balance
After 2026-06-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-16 · Grant · Acquired 20,604 · Balance 20,604 F2: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 16, 2026, such that the total number of shares will be fully vested on June 16, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that shall fully vest on the first anniversary of the date of grant.
F2: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 16, 2026, such that the total number of shares will be fully vested on June 16, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2026 Filed Jun 22, 2026 20:01 UTC | Xencor Inc XNCR · Entity 4487 | SaleCommon Stock | 6,843 | $13.06 | $89,369.58 |
DisclosureSEC source: 0001758108-26-000002 · wk-form4_1782158491.xml · nonDerivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,340 F1 · kind: This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 26, 2025. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:15 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantStock Option (Right to Buy) · Derivative | 2,340 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0000905148-26-003047 · form4.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,340 Underlying: Common Stock · 2,340 shares Expires 2036-06-17 F1 · derivative.exercise_date: The option vests in full on the earlier of June 18, 2027 and the date of the 2027 Annual Meeting of Stockholders. Read SEC document |
| June 16, 2026 Filed Jul 8, 2026 22:55 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (Right to Buy) · Derivative | 20,604 | $0.00 Strike: $12.20 | $0.00 |
DisclosureSEC source: 0001758108-26-000004 · wk-form4_1783551318.xml · derivative · entry 2 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,604 Underlying: Common Stock · 20,604 shares Expires 2036-06-15 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 16, 2026, such that the total number of shares will be fully vested on June 16, 2027. Read SEC document |
| June 16, 2026 Filed Jul 8, 2026 22:55 UTC | Xencor Inc XNCR · Entity 4487 | GrantCommon Stock | 10,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001758108-26-000004 · wk-form4_1783551318.xml · nonDerivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,642 F1 · shares: Represents restricted stock units that shall fully vest on the first anniversary of the date of grant. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 20:30 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantStock Option (Right to Buy) · Derivative | 18,700 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0000905148-25-002241 · form4.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,700 Underlying: Common Stock · 18,700 shares Expires 2035-06-19 F1 · derivative.exercise_date: The option vests in full on the earlier of June 20, 2026 and the date of the 2026 Annual Meeting of Stockholders. Read SEC document |
| June 16, 2025 Filed Jun 16, 2025 23:26 UTC | Xencor Inc XNCR · Entity 4487 | SaleCommon Stock | 2,993 | $9.22 | $27,595.46 |
DisclosureSEC source: 0001127602-25-017593 · form4.xml · nonDerivative · entry 2 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,183 F2 · kind: This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 23:26 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (Right to Buy) · Derivative | 27,372 | $0.00 Strike: $9.43 | $0.00 |
DisclosureSEC source: 0001127602-25-017593 · form4.xml · derivative · entry 3 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,372 Underlying: Common Stock · 27,372 shares Expires 2035-06-11 F3 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 12, 2025, such that the total number of shares will be fully vested on June 12, 2026. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 23:26 UTC | Xencor Inc XNCR · Entity 4487 | GrantCommon Stock | 13,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-017593 · form4.xml · nonDerivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,176 F1 · shares: Represents restricted stock units that shall fully vest on the first anniversary of the date of grant. Read SEC document |
| September 27, 2024 Filed Oct 1, 2024 20:07 UTC | Xencor Inc XNCR · Entity 4487 | SaleCommon Stock | 2,503 | $20.68 | $51,762.04 |
DisclosureSEC source: 0001127602-24-024662 · form4.xml · nonDerivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,490 F1 · shares: Sale was pursuant to a 10b5-1 plan arranged to cover withholding taxes upon vesting of restricted stock units. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 21:03 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantStock Option (Right to Buy) · Derivative | 18,700 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000905148-24-001765 · form4.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,700 Underlying: Common Stock · 18,700 shares Expires 2034-06-19 F1 · derivative.exercise_date: The option vests in full on the earlier of June 20, 2025 and the date of the 2025 Annual Meeting of Stockholders. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 20:23 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (Right to Buy) · Derivative | 11,971 | $0.00 Strike: $21.31 | $0.00 |
DisclosureSEC source: 0001127602-24-018834 · form4.xml · derivative · entry 2 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,971 Underlying: Common Stock · 11,971 shares Expires 2034-06-12 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 13, 2024, such that the total number of shares will be fully vested on June 13, 2025. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 20:23 UTC | Xencor Inc XNCR · Entity 4487 | GrantCommon Stock | 5,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-018834 · form4.xml · nonDerivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,993 F1 · shares: Represents restricted stock units that shall fully vest on the first anniversary of the date of grant. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:30 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001140361-23-031190 · form4.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2033-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 21:53 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (Right to Buy) · Derivative | 10,013 | $0.00 Strike: $26.19 | $0.00 |
DisclosureSEC source: 0001127602-23-019286 · form4.xml · derivative · entry 2 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,013 Underlying: Common Stock · 10,013 shares Expires 2033-06-20 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 20, 2023, such that the total number of shares will be fully vested on June 20, 2024. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 21:53 UTC | Xencor Inc XNCR · Entity 4487 | GrantCommon Stock | 5,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019286 · form4.xml · nonDerivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,007 F1 · shares: Represents restricted stock units that shall fully vest on the first anniversary of the date of grant. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 21:33 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0001567619-22-013373 · doc1.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2032-06-22 F1 · derivative.exercise_date: The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:34 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (Right to Buy) · Derivative | 21,412 | $0.00 Strike: $26.58 | $0.00 |
DisclosureSEC source: 0001127602-22-018157 · form4.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,412 Underlying: Common Stock · 21,412 shares Expires 2032-06-23 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 23, 2022, such that the total number of shares will be fully vested on June 23, 2023. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:08 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantStock Option (Right to Buy) · Derivative | 10,384 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0001567619-21-017925 · doc1.xml · derivative · entry 2 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,384 Underlying: Common Stock · 10,384 shares Expires 2031-09-30 F2 · derivative.exercise_date: The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:08 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantStock Option (Right to Buy) · Derivative | 28,500 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0001567619-21-017925 · doc1.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2031-09-30 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on October 1, 2021. Read SEC document |
| June 24, 2021 Filed Jun 26, 2021 00:01 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (Right to Buy) · Derivative | 9,728 | $0.00 Strike: $36.01 | $0.00 |
DisclosureSEC source: 0001415889-21-003231 · form4-06252021_080615.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,728 Underlying: Common Stock · 9,728 shares Expires 2031-06-24 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 24, 2021, such that the total number of shares will be fully vested on June 24, 2022. Read SEC document |
| June 25, 2020 Filed Jun 30, 2020 00:47 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (Right to Buy) · Derivative | 13,953 | $0.00 Strike: $33.42 | $0.00 |
DisclosureSEC source: 0001209191-20-039318 · doc4.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,953 Underlying: Common Stock · 13,953 shares Expires 2030-06-24 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 25, 2020, such that the total number of shares will be fully vested on June 25, 2021. Read SEC document |
| June 26, 2019 Filed Jun 27, 2019 23:51 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (Right to Buy) · Derivative | 12,731 | $0.00 Strike: $39.08 | $0.00 |
DisclosureSEC source: 0001209191-19-039386 · doc4.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,731 Underlying: Common Stock · 12,731 shares Expires 2029-06-25 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 26, 2019, such that the total number of shares will be fully vested on June 26, 2020. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:20 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (Right to Buy) · Derivative | 15,037 | $0.00 Strike: $41.69 | $0.00 |
DisclosureSEC source: 0001209191-18-057952 · doc4.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,037 Underlying: Common Stock · 15,037 shares Expires 2028-11-06 F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option vest and become exercisable on November 7, 2019, and the remaining shares vest in equal monthly installments over the subsequent 24 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.